GV 2019 Gp, L.P., Insider at Verve Therapeutics, Inc. (VERV), sold 303,182 shares at $38.94 ($8.3M) on 2022-10-31, disclosed to the SEC on 2022-11-02.
Open-market sale of $8.3M VERV by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 53,697 | $0 | 0.0% |
| 2 | $37.91 | 23,732 | $900K | 10.8% |
| 3 | $37.91 | 23,732 | $900K | 10.8% |
| 4 | $38.94 | 23,276 | $906K | 10.9% |
| 5 | $38.94 | 23,275 | $906K | 10.9% |
| 6 | $38.94 | 23,275 |
| $906K |
| 10.9% |
| 7 | $38.94 | 23,276 | $906K | 10.9% |
| 8 | $40.16 | 6,601 | $265K | 3.2% |
| 9 | $40.16 | 6,601 | $265K | 3.2% |
| 10 | $40.64 | 88 | $4K | 0.0% |
| 11 | $0.00 | 31,963 | $0 | 0.0% |
| 12 | $36.69 | 29,326 | $1.1M | 13.0% |
| 13 | $36.69 | 29,326 | $1.1M | 13.0% |
| 14 | $37.82 | 2,377 | $90K | 1.1% |
| 15 | $37.82 | 2,377 | $90K | 1.1% |
| 16 | $38.64 | 260 | $10K | 0.1% |
| Total | $27.38 avg | 303,182 | $8.3M | 100% |